| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/29/2010 | US7745387 Use of erythropoietin |
| 06/29/2010 | US7745174 co-expressing two heterotypes of Hepatocyte Growth Factor (HGF) comprising transforming or transfecting to a cell a DNA construct; for prevention and treatment of ischemic and liver disorders |
| 06/29/2010 | US7745139 for eliminating specifically binding, cell-physiologically active, pathological antibodies in preeclampsia and malign hypertension |
| 06/29/2010 | US7745137 analyzing two polymorphisms in stromelysin 1 gene and plasminogen activator inhibitor-1 gene in a nucleic acid sample; high accuracy and predictability |
| 06/29/2010 | US7744909 Dispersions for the formulation of slightly or poorly soluble agents |
| 06/29/2010 | CA2455628C Neuroprotective drug comprising flibanserin |
| 06/29/2010 | CA2453516C Alpha-ketoglutarates of l-carnitine and alkanoyl l-carnitine and compositions thereof |
| 06/29/2010 | CA2418070C Hybrid neuroprosthesis for the treatment of brain disorders |
| 06/29/2010 | CA2417942C 2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 06/29/2010 | CA2404737C Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug |
| 06/29/2010 | CA2354557C Methods to inactivate n-type calcium channels |
| 06/29/2010 | CA2345985C Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives,processes for their preparation, pharmaceuticals comprising these compounds and their use |
| 06/29/2010 | CA2289600C Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes |
| 06/29/2010 | CA2187740C Dna encoding bradykinin b1 receptor |
| 06/24/2010 | WO2010071853A1 Thiazolopyridine sirtuin modulating compounds |
| 06/24/2010 | WO2010071813A1 AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-α |
| 06/24/2010 | WO2010071783A1 Thiazoles as cannabinoid receptor ligands |
| 06/24/2010 | WO2010071391A1 Method for obtainment of protein hydrolysates with antihypertensive activity from amaranth grain |
| 06/24/2010 | WO2010071164A1 Activated blood coagulation factor x (fxa) inhibitor |
| 06/24/2010 | WO2010070022A1 Novel compounds |
| 06/24/2010 | WO2010069859A1 Cyclohexanecarboxamide derivatives useful as inhibitors of cholesteryl ester transfer protein |
| 06/24/2010 | WO2010069605A2 Oxidized cardiolipin as a novel pro-inflammatory factor |
| 06/24/2010 | WO2010069141A1 A controlled-released osmotic pump tablet with lubricating layer and the preparation thereof |
| 06/24/2010 | WO2010069140A1 Medicinal product of oryzanol and preparation method thereof |
| 06/24/2010 | WO2010069139A1 Pharmaceutical composition and preparation method thereof |
| 06/24/2010 | WO2010069138A1 Oryzanol composition and preparation method thereof |
| 06/24/2010 | WO2010069090A2 Pharmaceutical composition containing angiotensin-(1-9) for cardiovascular, pulmonary and/or cerebral treatment |
| 06/24/2010 | WO2010069073A1 Combination of photodynamic therapy and anti-vegf agents in the treatment of unwanted choroidal neovasculature |
| 06/24/2010 | WO2010049709A3 Therapeutic compositions comprising phenolic acids for treating conditions related to inap proriate platelet aggregation |
| 06/24/2010 | WO2010049705A3 Therapeutic compositions comprising flavonoids |
| 06/24/2010 | WO2010037856A3 DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS |
| 06/24/2010 | WO2010010112A3 Construct and method for the internalization of cargo molecules into a cell |
| 06/24/2010 | WO2009106470A3 Angiotensin ii receptor antagonists |
| 06/24/2010 | WO2009074498A8 Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate |
| 06/24/2010 | US20100160721 Cardiac support device with differential compliance |
| 06/24/2010 | US20100160620 N-pyrazole a2a receptor agonists |
| 06/24/2010 | US20100160448 Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury |
| 06/24/2010 | US20100160444 Method to inhibit ischemia and reperfusion injury |
| 06/24/2010 | US20100160441 Novel compounds |
| 06/24/2010 | US20100160433 Treatment of neurodegenerative and cardiovascular disorders |
| 06/24/2010 | US20100160427 Method of treating vascular injuries induced by an excess of plasma lipids using combinations of vasoprotective agents |
| 06/24/2010 | US20100160424 Renin inhibitors |
| 06/24/2010 | US20100160409 Highly Branched Reagents For Modifying Biopharmaceuticals, Their Preparation And Use |
| 06/24/2010 | US20100160404 New crystalline forms of perindopril erbumine |
| 06/24/2010 | US20100160400 Treatment using dantrolene |
| 06/24/2010 | US20100160386 4-phenoxy-nicotine acid derivatives and use thereof as ppar-modulators |
| 06/24/2010 | US20100160383 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation |
| 06/24/2010 | US20100160372 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 06/24/2010 | US20100160367 Pharmaceutical compositions containing pyrroloquinoline quinone and nephroprotectant for treating ischemia reperfusion injuries |
| 06/24/2010 | US20100160366 Treatment method |
| 06/24/2010 | US20100160361 Treatment of major adverse cardiac events and acute coronary syndrome using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapies |
| 06/24/2010 | US20100160358 Pyridylsulfonamidyl-Pyrimidines for the Prevention of Blood Vessel Graft Failure |
| 06/24/2010 | US20100160356 Novel cyclobutyl compounds as kinase inhibitors |
| 06/24/2010 | US20100160354 Novel compounds |
| 06/24/2010 | US20100160353 Pharmaceutical composition and beverage composition comprising l-arginine |
| 06/24/2010 | US20100160347 PYRIDO[1,2-a]PYRIMIDIN-4-ONE INHIBITORS OF MAST CELL DEGRANULATION |
| 06/24/2010 | US20100160344 Novel compounds |
| 06/24/2010 | US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160332 a2-Adrenoceptor Ligands |
| 06/24/2010 | US20100160328 New compounds useful for dpp-iv enzyme inhibition |
| 06/24/2010 | US20100160320 C5aR ANTAGONISTS |
| 06/24/2010 | US20100160318 3-Pyrrolo[b]Cyclohexylene-2-Dihydroindolinone Derivatives and Uses Thereof |
| 06/24/2010 | US20100160287 Compounds useful as inhibitors of janus kinases |
| 06/24/2010 | US20100160282 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 06/24/2010 | US20100160259 Dosage regimen for a s1p receptor agonist |
| 06/24/2010 | US20100160255 Spiro-cyclic compound |
| 06/24/2010 | US20100160245 Quercetin-Containing Compositions |
| 06/24/2010 | US20100160238 TGFP-CAP Peptide and its Uses |
| 06/24/2010 | US20100160230 Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system |
| 06/24/2010 | US20100160228 Method for inhibiting or stimulating angiogenesis in an individual |
| 06/24/2010 | US20100160225 Lefty, lefty derivatives and uses thereof |
| 06/24/2010 | US20100159607 Il1rl-1 as a cardiovascular disease marker and therapeutic target |
| 06/24/2010 | US20100159044 Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans |
| 06/24/2010 | US20100159032 Combinations useful for the treatment of neuronal disorders |
| 06/24/2010 | US20100159005 COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS |
| 06/24/2010 | US20100158999 Combination of triazine derivatives and hmg-coa reductase inhibitors |
| 06/24/2010 | US20100158996 Ester compound and medical use thereof |
| 06/24/2010 | US20100158995 Systems for delivery and release of angiotensin-(1-7) |
| 06/24/2010 | US20100158990 Transdermal method and patch for corticosteroid administration |
| 06/24/2010 | US20100158988 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 06/24/2010 | US20100158979 Temporal release of growth factors from 3d micro rod scaffolds for tissue regeneration |
| 06/24/2010 | US20100158975 Extracellular matrix compositions |
| 06/24/2010 | US20100158974 Coated implant |
| 06/24/2010 | US20100158973 Therapeutic uses of cannabidiol compounds |
| 06/24/2010 | US20100158971 Method for reducing the likelihood of preeclampsia in a subject in need thereof |
| 06/24/2010 | US20100158959 Stable Combinations of Amlodipine Besylate and Benazepril Hydrochloride |
| 06/24/2010 | US20100158941 Compositions and Methods for Treating Microbial Infections |
| 06/24/2010 | US20100158924 Expression of the cysteine protease legumain in vascular and inflammatory diseases |
| 06/24/2010 | US20100158922 Anti-Interferon Gamma Antibodies and Methods of Use Thereof |
| 06/24/2010 | US20100158914 Klotho beta |
| 06/24/2010 | US20100158900 Anti-marinobufagenin antibodies and methods for their use |
| 06/24/2010 | US20100158874 Compositions and Methods for Treating Peripheral Vascular Diseases |
| 06/24/2010 | US20100158867 Paramyxovirus vector encoding angiogenesis gene and use thereof |
| 06/24/2010 | US20100158817 T1 mri trackable drug delivery particles, uses and methods thereof |
| 06/24/2010 | US20100158811 Assessing brain aneurysms |
| 06/24/2010 | US20100158805 Quantum dot labeled stem cells for use in cardiac repair |
| 06/24/2010 | DE102008064588A1 Nahrungsergänzungsmittel auf der Basis von Pantothensäure Food supplements based on pantothenic acid |
| 06/24/2010 | DE102008061247A1 Inhibitoren der Dimethylarginin Dimethylaminohydrolase Inhibitors of dimethylarginine dimethylaminohydrolase |
| 06/24/2010 | CA2747715A1 Thiazolopyridine sirtuin modulating compounds |